Home › UPDATE 1-U.S. FDA approves Teva's biotech drug for severe asthma
 

Keywords :   


UPDATE 1-U.S. FDA approves Teva's biotech drug for severe asthma

2016-03-23 21:16:09| Biotech - Topix.net

The U.S. Food and Drug Administration said on Wednesday it had approved Teva Pharmaceutical Industries Ltd's drug to treat asthma in adults who have a history of severe attacks despite taking medication. The drug, Cinqair, part of a new wave of biotech drugs for severe asthma, is administered intravenously every four weeks in combination with other drugs.

Tags: update drug severe biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
21.05Eastern North Pacific Tropical Weather Outlook
21.05Atlantic Tropical Weather Outlook
20.05Dantex USA appoints Rob Tolland VP of sales
20.05MDARD designates two bovine tuberculosis testing areas
20.05USDA moves to electronic identification tags
20.05Better pasture and hay conditions anticipated for 2024
20.05Panasonic offers Fire TV, Google TV and Powered by TiVo
20.05Eutelsat reports results for the period ended 31 March 2024
More »